OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GDTC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

CytoMed Therapeutics (GDTC) Earnings Date & Reports

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GDTC is expected to report earnings to fall 66.67% to -3 cents per share on November 14

CytoMed Therapeutics GDTC Stock Earnings Reports

Q2'25

Est.

$-0.04

Q4'24

Missed

by $0.08

Q3'24

Est.

$-0.04

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.04

The last earnings report on May 05 showed earnings per share of -11 cents, missing the estimate of -3 cents. With 3.27K shares outstanding, the current market capitalization sits at 21.58M.

View a ticker or compare two or three

Compare

GDTC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GDTC
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GDTC showed earnings on May 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1 Commonwealth Lane

Phone

+65 62507738

Employees

Web

https://w2.cytomed.sg